Harbor Capital Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History
Harbor Capital Advisors, Inc.
- $2.38 Billion
- Q2 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 17,884 shares of COLL stock, worth $576,937. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,884
Previous 20,841
14.19%
Holding current value
$576,937
Previous $622,000
14.95%
% of portfolio
0.02%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding COLL
# of Institutions
253Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$187 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$96.8 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$85.2 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$72.5 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$52.7 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.1B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...